Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M161,772Revenue $M42,237Net Margin (%)27.0Altman Z-Score3.2
Enterprise Value $M176,557EPS $4.1Operating Margin %12.5Piotroski F-Score4
P/E(ttm)14.9Beneish M-Score-2.9Pre-tax Margin (%)40.0Higher ROA y-yY
Price/Book3.410-y EBITDA Growth Rate %5.4Quick Ratio1.3Cash flow > EarningsN
Price/Sales4.05-y EBITDA Growth Rate %4.0Current Ratio1.6Lower Leverage y-yN
Price/Free Cash Flow30.6y-y EBITDA Growth Rate %75.5ROA % (ttm)10.9Higher Current Ratio y-yN
Dividend Yield %3.1PEG3.7ROE % (ttm)23.3Less Shares Outstanding y-yY
Payout Ratio %46.0Shares Outstanding M2,825ROIC % (ttm)6.5Gross Margin Increase y-yN

Gurus Latest Trades with MRK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MRKKahn Brothers 2015-06-30 Reduce-0.13%$56.73 - $60.89
($58.76)
$ 57.26-3%Reduce 1.28%1,016,613
MRKKen Fisher 2015-06-30 Add0.02%$56.73 - $60.89
($58.76)
$ 57.26-3%Add 2.35%6,836,547
MRKVanguard Health Care Fund 2015-03-31 Add0.53%$56.06 - $63.03
($59.34)
$ 57.26-4%Add 12.04%40,096,948
MRKDodge & Cox 2015-03-31 Reduce-0.44%$56.06 - $63.03
($59.34)
$ 57.26-4%Reduce 24.30%25,448,977
MRKKahn Brothers 2015-03-31 Reduce-0.22%$56.06 - $63.03
($59.34)
$ 57.26-4%Reduce 2.18%1,029,815
MRKJoel Greenblatt 2015-03-31 Reduce-0.17%$56.06 - $63.03
($59.34)
$ 57.26-4%Reduce 35.28%676,758
MRKJames Barrow 2015-03-31 Add0.13%$56.06 - $63.03
($59.34)
$ 57.26-4%Add 7.03%24,464,116
MRKCharles Brandes 2015-03-31 Reduce-0.07%$56.06 - $63.03
($59.34)
$ 57.26-4%Reduce 3.69%2,221,791
MRKNWQ Managers 2015-03-31 Reduce-0.01%$56.06 - $63.03
($59.34)
$ 57.26-4%Reduce 9.00%76,286
MRKMario Gabelli 2015-03-31 Add0.01%$56.06 - $63.03
($59.34)
$ 57.26-4%Add 11.45%160,943
MRKKen Fisher 2015-03-31 Add$56.06 - $63.03
($59.34)
$ 57.26-4%Add 0.59%6,679,499
MRKKahn Brothers 2014-12-31 Reduce-0.54%$53.43 - $61.88
($58.42)
$ 57.26-2%Reduce 5.08%1,052,807
MRKVanguard Health Care Fund 2014-12-31 Add0.32%$53.43 - $61.88
($58.42)
$ 57.26-2%Add 7.08%35,788,048
MRKJoel Greenblatt 2014-12-31 Add0.23%$53.43 - $61.88
($58.42)
$ 57.26-2%Add 94.88%1,045,652
MRKFirst Eagle Investment 2014-12-31 Reduce-0.16%$53.43 - $61.88
($58.42)
$ 57.26-2%Reduce 99.16%9,050
MRKJoel Greenblatt 2014-09-30 Add0.24%$55.64 - $61.18
($58.89)
$ 57.26-3%Add 323.00%536,550
MRKFirst Eagle Investment 2014-09-30 Reduce-0.1%$55.64 - $61.18
($58.89)
$ 57.26-3%Reduce 38.25%1,083,826
MRKKahn Brothers 2014-09-30 Reduce-0.09%$55.64 - $61.18
($58.85)
$ 57.26-3%Reduce 0.97%1,109,189
MRKCharles Brandes 2014-09-30 Reduce-0.08%$55.64 - $61.18
($58.85)
$ 57.26-3%Reduce 4.69%2,320,288
MRKVanguard Health Care Fund 2014-09-30 Reduce-0.07%$55.64 - $61.18
($58.85)
$ 57.26-3%Reduce 1.38%33,420,748
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MRK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MRK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Schechter Adam HEVP & Pres-Global Human Health 2015-05-11Sell10,634$60.44-5.26view
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy 2015-05-08Sell38,368$60.99-6.12view
Kuhlik Bruce NExe V-P & Gen Counsel 2015-05-04Sell56,064$60.2-4.88view
Holston Michael JEVP, Legal 2015-04-29Sell95,624$59.84-4.31view
Kuhlik Bruce NExe V-P & Gen Counsel 2015-04-29Sell156,902$59.82-4.28view
FRAZIER KENNETH CChairman, President & CEO 2015-02-18Sell5,164$58.67-2.4view
Deese Willie AExe V-P & Pres. MMD 2015-02-11Sell135,864$58.56-2.22view
WENDELL PETER CDirector 2015-02-09Sell5,000$58.76-2.55view
Schechter Adam HEVP & Pres-Global Human Health 2015-01-15Sell74,200$62.48-8.35view
FRAZIER KENNETH CChairman, President & CEO 2015-01-09Sell8,840$62.47-8.34view

Press Releases about MRK :

Quarterly/Annual Reports about MRK:

    News about MRK:

    Articles On GuruFocus.com
    Manning & Napier Advisors' Most Weighted Trades in Q2 2015 Jul 10 2015 
    Intrexon Corp is expanding his business Jun 25 2015 
    Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The Cost Tells A Different Story Jun 22 2015 
    Will GlaxoSmithKline Cut Its 6% Dividend? Jun 03 2015 
    Abbvie Inc. Dividend Stock Analysis May 26 2015 
    Endo International Acquires Par Pharmaceuticals For $8 Billion May 21 2015 
    Risk & Reward with Gilead Sciences Inc. (GILD) May 14 2015 
    Vanguard Adds to Four of Its Largest Stakes May 04 2015 
    Biogen Making A Breakthrough In Treating Alzheimer’s May 02 2015 
    Robert Bruce's Top Growth Stocks Apr 13 2015 

    More From Other Websites
    These High-Quality Companies Are on Sale Jul 29 2015
    The Top Drug Launches Of All Time Jul 29 2015
    Merck Earnings Hurt by Arthritis Drug Knockoffs Jul 28 2015
    Gilead beats Street 2Q forecasts on surge in sales, profit Jul 28 2015
    Gilead beats Street 2Q forecasts on surge in sales, profit Jul 28 2015
    Pfizer, Merck Beat Q2 Views; Sanofi Makes PD-1 Deal Jul 28 2015
    Merck (MRK) Earnings Report: Q2 2015 Conference Call Transcript Jul 28 2015
    MERCK & CO., INC. Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to... Jul 28 2015
    Merck Adds Johns Hopkins Dean, Former Accenture CFO to Board Jul 28 2015
    Pamela J. Craig and Dr. Paul B. Rothman Elected to Merck Board of Directors Jul 28 2015
    Edited Transcript of MRK earnings conference call or presentation 28-Jul-15 12:00pm GMT Jul 28 2015
    Drugmaker Pfizer tops Street 2Q forecasts, raises forecast Jul 28 2015
    Drugmaker Pfizer tops Street 2Q forecasts, raises forecast Jul 28 2015
    Gilead Sciences: How Will the Market React to Slowing U.S. Hep-C Sales? Jul 28 2015
    Stocks Higher after Multiday Slide Jul 28 2015
    Merck Tops on Q2 Earnings & Revenues, Revises Outlook - Analyst Blog Jul 28 2015
    Merck tops Street 2Q forecasts despite lower sales, profit Jul 28 2015
    Merck tops Street 2Q forecasts despite lower sales, profit Jul 28 2015
    Merck (MRK) Stock Retreating Despite Earnings Beat Jul 28 2015
    Are Merck Earnings Enough? Jul 28 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK